Augmentace antidepresiv atypickými antipsychotiky v léčbě farmakorezistentní deprese

• Title in English: Augmentation of antidepressants with atypical antipsychotics in the treatment of pharmacoresistant depression
• Authors: ČEŠKOVÁ Eva
• Year of publication: 2011
• Type: Article in Periodical
• Magazine / Source: Česká a slovenská psychiatrie
• MU Faculty or unit: Central European Institute of Technology
• Field: Psychiatry, sexuology
• Keywords: augmentation; antidepressants; atypical antipsychotics; risperidone; olanzapine; aripiprazol; quetiapine; quatiapine XR
• Description: Augmentation of antidepressants with atypical antipsychotics presents an often used strategy in the treatment of pharmacoresistant depression. This strategy is common in both out-patient and in-patient departments. Controlled studies were performed with risperidone, olanzapine, aripiprazol and quetiapine. Quetiapine XR it the first atypical antipsychotic in the Czech Republic proved as adjunctive treatment in depressive episodes non responding adequately to monotherapy with antidepressants.

Related projects

• The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.